Clinical Trial Update: Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE) [NA]

View source ↗

Summary

The ECLIPSE study is enrolling by invitation to longitudinally monitor epilepsy in order to inform personalized seizure-risk estimation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Epilepsy (Treatment Refractory) | NA | Status: ENROLLING_BY_INVITATION